BRD4 and hypertensive disorder: Four time points were selected for the pulse of the OGTAC treatment,and the rhodamine signal on HTN-BRD4 was evaluated by in-gel fluorescence;a weaker rhodamine signal indicated that more of the OGTACs had alreadyreacted with the HaloTag, thereby blocking the binding of the rhodamineligand.